At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-blind, Placebo and Active-controlled, Parallel-group Study to Evaluate the Analgesic Efficacy and Safety of Dexketoprofen Trometamol and Tramadol Hydrochloride Oral Fixed Combination on Moderate to Severe Acute Pain After Elective Unilateral Total Hip Arthroplasty
In Brief
A Phase 3 clinical trial evaluating Placebo, Tramadol-single dose, and 5 other interventions for Acute Pain. Completed, enrolled 641 participants across 37 sites in 10 countries.
Detailed Summary
This study aims to evaluate the analgesic efficacy of single and repeated doses of fixed combination of dexketoprofen trometamol (DKP) and tramadol hydrochloride (TRAM) in comparison to the single agents (and placebo for the single dose phase only) Approximately 600 male and female patients presenting moderate to severe pain after an elective primary hip arthroplasty are eligible to be randomised provided that they experience moderate to severe pain on the day after surgery.
Study Details
Timeline
Interventions
Placebo single oral dose (first 8 hours)
Tramadol single oral dose (first 8 hours)
Dexketoprofen single oral dose (first 8 hours)
Dexketoprofen/Tramadol oral single dose (first 8 hours)
Tramadol multiple oral doses t.i.d. for 5 days (total 12 doses)
Dexketoprofen multiple oral doses t.i.d. for 5 days (total 12 doses)
Dexketoprofen/Tramadol multiple oral doses t.i.d. for 5 days (total 12 doses)